ClinicalTrials.Veeva

Menu

ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI)

U

University of Leipzig

Status

Withdrawn

Conditions

Non-ST-elevation Myocardial Infarction

Treatments

Procedure: immediate angiography and revascularization
Procedure: early invasive angiography

Study type

Interventional

Funder types

Other

Identifiers

NCT00954668
IDEAL NSTEMI 1

Details and patient eligibility

About

Of estimated 140,000 cases of acute myocardial infarction admitted to hospitals in Germany per year, approximately 50% present with Non-ST-elevation myocardial infarction (NSTEMI). The currently available evidence led to current guideline recommendations that a systematic approach of immediate angiography in NSTEMI patients stabilized with contemporary antiplatelet treatment is not mandatory. However, this immediate invasive approach is appealing because it allows treating the underlying cause (the plaque rupture) as early as possible with subsequent reduction of death and recurrent myocardial infarction. In the IDEAL NSTEMI trial we test an immediate invasive approach (<2 h) with an approach 12-72 h according top guidelines with respect to 6 months death and mortality.

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NSTEMI with

    • ischemic symptoms >10 minutes within 24 h
    • elevated troponin or creatine kinase above the upper limit of normal
    • ST-segment depression or transient ST-segment elevation, T-wave inversion
    • informed consent.

Exclusion criteria

  • Age < 18 years
  • Age > 90 years
  • persistent angina
  • hemodynamic instability
  • overt congestive heart failure
  • life-threatening arrhythmias
  • STEMI
  • limited life-expectancy < 6 months
  • chronic oral anticoagulation
  • fibrinolysis < 48 hours
  • PCI < 14 days
  • contraindication for treatment with glycoprotein IIb/IIIa inhibitors, heparin, aspirin and clopidogrel
  • recent major trauma or surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

immediate angiography
Experimental group
Description:
Immediate invasive angiography \< 2 h after randomization
Treatment:
Procedure: immediate angiography and revascularization
early invasive angiography
Active Comparator group
Description:
early invasive angiography 12-72 h after randomization
Treatment:
Procedure: early invasive angiography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems